Bio-Techne CEO to present at Bank of America Healthcare Conference on May 12, 2026

Bio-Techne Corporation announced that its President and CEO, Kim Kelderman, will present at the Bank of America Securities 2026 Global Healthcare Conference on May 12, 2026. The presentation will be webcast live and accessible through Bio-Techne's Investor Relations website. Bio-Techne is a global life sciences company with a strong presence in research, diagnostics, and biotechnology, generating over $1.2 billion in net sales in fiscal year 2025. This event provides an opportunity for investors to hear directly from the company's leadership about its strategies and future outlook.